Scotia Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
VCM
VPM
Scotia Capital's ZBH Position: Q1 2026 in Review
Scotia Capital reduced its Zimmer Biomet (ZBH) stake by 22% in Q1 2026, selling an estimated $145K and leaving 5,590 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #676.
Scotia Capital first reported a position in ZBH in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.88M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Scotia Capital held 5,590 shares of Zimmer Biomet worth $505K as of Q1 2026.
- Scotia Capital sold 1,575 Zimmer Biomet shares in Q1 2026, an estimated $145K.
- Zimmer Biomet made up ﹤0.01% of Scotia Capital's portfolio in Q1 2026, its #676 holding.
- Scotia Capital first reported a position in Zimmer Biomet in Q3 2020 and has held it in 15 quarters since.
- Scotia Capital's Zimmer Biomet position peaked at $1.88M in Q4 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.